Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Inventory (2018 - 2025)

Historic Inventory for BioNexus Gene Lab (BGLC) over the last 8 years, with Q3 2025 value amounting to $1.0 million.

  • BioNexus Gene Lab's Inventory fell 2747.35% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 2747.35%. This contributed to the annual value of $1.4 million for FY2024, which is 2204.79% up from last year.
  • BioNexus Gene Lab's Inventory amounted to $1.0 million in Q3 2025, which was down 2747.35% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, BioNexus Gene Lab's Inventory peaked at $1.7 million during Q2 2021, and registered a low of $899636.0 during Q1 2023.
  • Moreover, its 5-year median value for Inventory was $1.2 million (2025), whereas its average is $1.3 million.
  • In the last 5 years, BioNexus Gene Lab's Inventory skyrocketed by 2027431.7% in 2021 and then crashed by 4544.03% in 2023.
  • Quarter analysis of 5 years shows BioNexus Gene Lab's Inventory stood at $1.5 million in 2021, then tumbled by 35.75% to $977807.0 in 2022, then rose by 16.36% to $1.1 million in 2023, then rose by 22.05% to $1.4 million in 2024, then fell by 27.45% to $1.0 million in 2025.
  • Its Inventory was $1.0 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.2 million in Q1 2025.